Clinical trial
Induction Chemotherapy Followed by Chemoradiation With Cetuximab and Cisplatin for Inoperable Squamous Cell Carcinoma of the Head and Neck
NCT00868491 is registered in ClinicalTrials.gov with Institute of Oncology Ljubljana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Induction Chemotherapy Followed by Chemoradiation With Cetuximab and Cisplatin for Inoperable Squamous Cell Carcinoma of the Head and Neck
- Lead sponsor
- Institute of Oncology Ljubljana
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2008
- Completion date
- October 30, 2011
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer